Mylan’s Other EpiPen Classification Issue and Unresolved Overhang

(This is an excerpt from an article I originally published on Seeking Alpha on October 19, 2016. Click here to read the entire piece.) Mylan (MYL) is down 13% (and as much as 17%) since I argued the company was “out of tune” with an angry chorus that promised to place a lot of short-term … Read more

The Pound Receives Some Relief As the UK PM Faces Brexit Constraints

(This is an excerpt from an article I originally published on Seeking Alpha on October 16, 2016. Click here to read the entire piece.) It looks like UK Prime Minister Theresa May will not be able to proceed with Brexit plans, hard or not, unchecked by other powers in the UK. The UK Parliament demanded … Read more

Bottoming Efforts: Deutsche Bank Follow-Through and First Solar Breakout

Deutsche Bank (DB) In early October, I pointed out the extreme in bearish sentiment on Deutsche Bank (DB) and the related overcrowding in bearish bets. After DB surged 14% off its latest all-time low, I decided to hold onto my call options which were a play on a bottom. So far, so good. DB printed … Read more

T2108 Update (October 19, 2016) – The S&P 500 Bounces Weakly from Near-Oversold

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

The Brazil ETF Continues Adding to A Tremendous 2016 Rally

Almost two months ago, I explained my decision to sell my position in iShares MSCI Brazil Capped (EWZ). I also pointed to a 20% correction as the next time I will consider buying again. Since then, EWZ rallied, dipped slightly to a lower low, and then resumed its current rally. That rally accelerated a bit … Read more